Journal profile · Medicine-Psychiatry and Mental Health
Dialogues in Clinical Neuroscience
ISSN 1294-8322 · eISSN 1958-5969 · Servier International · FRANCE
Dialogues in Clinical Neuroscience: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 5.05; JCR Q1 (journal website); fully open access; APC charged, amount not published; median 197 days to acceptance (50 articles, last 24 months); acceptance rate 21% (journal website); 23 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Dialogues in Clinical Neuroscience is published by Servier International and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Schizophrenia research and treatment, Functional Brain Connectivity Studies and Treatment of Major Depression, together about 22% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Dialogues in Clinical Neuroscience (DCNS) aims to serve as an interface between clinical neuropsychiatry and the neurosciences by providing state-of-the-art information and original insights into relevant clinical, biological, and therapeutic aspects. DCNS is an open access journal. Each issue will be composed of expert reviews, original articles and brief reports. Unsolicited submissions are welcomed.All research articles in this journal have undergone rigorous peer review, based on initial editor screening and anonymous peer review. Read the Instructions for Authors .
From the journal's Aims & Scope
Research area (LetPub): Medicine-Psychiatry and Mental Health
Editorial board by country: none in mainland China; most named India 3, France 2, Israel 2, Hong Kong, China 1, United States 1 (14 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Schizophrenia research and treatmentMedicine8.9%
- Functional Brain Connectivity StudiesNeuroscience6.8%
- Treatment of Major DepressionMedicine6.2%
- Tryptophan and brain disordersNeuroscience6.1%
- Neurotransmitter Receptor Influence on BehaviorNeuroscience5.6%
- Stress Responses and CortisolNeuroscience5.4%
- Mental Health Research TopicsPsychology4.9%
- Mental Health and PsychiatryArts and Humanities4.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Neurosciences | Zone 2 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Neurosciences | Zone 1 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Neurosciences | Zone 2 |
Top journal: noReview journal: no
JCR / CiteScore quartiles on the journal's website
- JCR Q1 · best quartile · 2025
- CiteScore Q1 · 2025
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEPubMedEmbasePublisher website
Other: Index Medicus, Elsevier Biobase
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 5.05LetPub ·
- Impact factor (publisher) 2025
- 5.1Publisher website ·
- 5-year impact factor (publisher) 2025
- 16.6Publisher website ·
- CiteScore 2026-06
- 6.3LetPub ·
- CiteScore (publisher) 2025
- 6.3Publisher website ·
- SJR 2026-06
- 1.51LetPub ·
- SJR (publisher) 2025
- 1.51Publisher website ·
- SNIP 2026-06
- 1.81LetPub ·
- SNIP (publisher) 2025
- 1.81Publisher website ·
- h-index
- 69LetPub ·
- h-index
- 155OpenAlex ·
- i10-index
- 731OpenAlex ·
- 2-year mean citedness
- 3.63OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 21LetPub ·
- Downloads per year (publisher)
- 1,100,000Publisher website ·
Articles by year OpenAlex count · 927 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 25 | 25 | 18 |
| 2025 | 23 | 23 | 147 |
| 2024 | 9 | 9 | 42 |
| 2023 | 12 | 12 | 301 |
| 2022 | 2 | 2 | 101 |
| 2021 | 7 | 7 | 228 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
197 daysMedian, submission to acceptance · P25–P75 139 days – 292 days
- Acceptance to online
- median 15 days (50 articles)
- Submission to online
- median 212 days
- Sample
- 50 articles with submission and acceptance dates (51 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Acceptance rate (publisher)
- 21%Publisher website ·
- Submission to first decision
- 17 daysPublisher website ·
- First decision after review
- 77 daysPublisher website ·
- Acceptance to publication
- 19 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteOpen access, Peer review
- Open access Open access
Dialogues in Clinical Neuroscience is an open access journal and only publishes open access articles. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research. Why choose open access? Increase the discoverability and readership of your article Make an impact and reach new readers, not…
Source ↗Publisher website ·- Peer review
Peer review policy Model summary
All research articles in this journal have undergone rigorous peer review, based on initial editor screening and anonymous peer review.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Servier International
- Country or region
- FRANCE
- Language
- English
- ISSN
- 1294-8322
- Electronic ISSN
- 1958-5969
- Society / sponsor
- World Federation of Societies of Biological Psychiatry
- Latest issue on the website
- Volume 28, Issue 1 (2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Dialogues in Clinical Neuroscience
What CAS zone is Dialogues in Clinical Neuroscience in?
In the 2025 upgraded edition of the CAS Journal Ranking, Dialogues in Clinical Neuroscience is in Zone 2 of Medicine, and in Zone 2 of the minor category Neurosciences. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Dialogues in Clinical Neuroscience?
The latest impact factor listed by LetPub is 5.05; CiteScore 6.3, h-index 155.
How long does peer review take at Dialogues in Clinical Neuroscience?
Based on the dates recorded on 50 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 197 days (interquartile range 139–292 days); the journal's website gives an acceptance rate of 21%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is Dialogues in Clinical Neuroscience in?
The journal's website gives JCR Q1 (best quartile). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 2 of Medicine.
Where are the editorial board members of Dialogues in Clinical Neuroscience based?
Of the 14 board members whose country the journal's board page names, none are in mainland China; the countries named most often are India (3), France (2) and Israel (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Dialogues in Clinical Neuroscience?
According to LetPub and DOAJ records, Dialogues in Clinical Neuroscience is indexed in SCIE, Scopus and DOAJ. The journal's website also lists MEDLINE, PubMed and Embase; that list has not been checked against each database.
Is Dialogues in Clinical Neuroscience open access, and what is the APC?
Dialogues in Clinical Neuroscience is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .